Truist Securities Maintains Buy on AdaptHealth, Maintains $13 Price Target
Portfolio Pulse from Benzinga Newsdesk
Truist Securities analyst David Macdonald maintains a Buy rating on AdaptHealth (NASDAQ:AHCO) with a $13 price target.
May 15, 2024 | 6:20 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Truist Securities analyst David Macdonald has reiterated a Buy rating on AdaptHealth (NASDAQ:AHCO) and maintained a $13 price target.
The reiteration of a Buy rating and a maintained price target of $13 by Truist Securities is a positive signal for investors, likely boosting short-term confidence and potentially driving the stock price up.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100